Risk factor
Resilient to price shocks
Profitability factor
Very strong margins and returns
About
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,
Target Price
The average target price of 4016.SR is 146 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell